UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (UNCY)

Q: What does CUSIP 90466Y103 represent in this 13F holders report?

CUSIP 90466Y103 is the security identifier for UNCY - UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

Q: How many institutions held UNCY - UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share in Q4 2023?

16 institutional investors reported UNCY - UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share for Q4 2023. Use the holders table for investor-level position and value details.

CUSIP: 90466Y103

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 18,578,488
Total 13F shares: 13,030,671
Share change: -1,162,143
Total reported value: $11,307,131
Price per share: $0.87
Number of holders: 16
Value change: -$1,007,258
Number of buys: 7
Number of sells: 6

Security key

90466Y103

Report period

Q4 2023

Institutions

Top holders

UNCY full security history Newer quarter: Q1 2024 Previous quarter: Q3 2023 Unicycive Therapeutics, Inc. SEC filings Unicycive Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 90466Y103

Newer quarter: Q1 2024 Previous quarter: Q3 2023

Recent filing periods:

Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023

Top shareholders of UNCY - UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
RA CAPITAL MANAGEMENT, L.P.	13F	Company	19%	3,470,688	$2,984,792	—	30 Sep 2023	13F
Nantahala Capital Management, LLC	13F	Company	19%	3,470,541	$2,984,666	—	30 Sep 2023	13F
Vivo Capital, LLC	13F	Company	19%	3,470,152	$2,984,331	—	30 Sep 2023	13F
BVF INC/IL	13F	Company	18%	3,413,563	$2,935,664	—	30 Sep 2023	13F
VANGUARD GROUP INC	13F	Company	0.62%	115,057	$98,949	—	30 Sep 2023	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.5%	93,233	$80,180	—	30 Sep 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.28%	52,399	$45,063	—	30 Sep 2023	13F
STATE STREET CORP	13F	Company	0.19%	35,036	$30,131	—	30 Sep 2023	13F
CAPTRUST FINANCIAL ADVISORS	13F	Company	0.1%	18,800	$16,168	—	30 Sep 2023	13F
TANDEM CAPITAL MANAGEMENT CORP /ADV	13F	Company	0.08%	15,500	$13,330	—	30 Sep 2023	13F
Beacon Pointe Advisors, LLC	13F	Company	0.06%	11,861	$10,200	—	30 Sep 2023	13F
TWO SIGMA SECURITIES, LLC	13F	Company	0.06%	11,165	$9,602	—	30 Sep 2023	13F
Virtu Financial LLC	13F	Company	0.06%	10,994	$9,000	—	30 Sep 2023	13F
Tower Research Capital LLC (TRC)	13F	Company	0.02%	3,068	$2,638	—	30 Sep 2023	13F
UBS Group AG	13F	Company	0%	718	$617	—	30 Sep 2023	13F
WELLS FARGO & COMPANY/MN	13F	Company	0%	39	$34	—	30 Sep 2023	13F
John L. Ryan	3/4/5	Director	— class O/S missing	123,775	—	—	05 Sep 2023	3/4/5
Brigitte Schiller	3/4/5	Director	— class O/S missing	41,738	—	—	15 Jul 2022	3/4/5

Institutional Holders of UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (UNCY) as of Q4 2023

As of 31 Dec 2023, UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (UNCY) was held by 16 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 13,030,671 shares. The largest 10 holders included RA CAPITAL MANAGEMENT, L.P., Vivo Capital, LLC, Nantahala Capital Management, LLC, BVF INC/IL, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, GOLDMAN SACHS GROUP INC, CITADEL ADVISORS LLC, STATE STREET CORP, and RENAISSANCE TECHNOLOGIES LLC. This page lists 16 institutional shareholders reporting positions in this security for the Q4 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2023 vs Q3 2023 Across Filers

Q3 2023 holders

Q4 2023 holders

Holder diff

Investor	Q3 2023 Shares	Q4 2023 Shares	Share Diff	Share Chg %	Q3 2023 Value $	Q4 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.